The results indicate that AdipoRon treatment attenuated inflammation, microvascular injury and fibrosis in the skin, and abrogated TGF-β-mediated and constitutive activation of normal and SSc fibroblasts. This evidence concerns the gene TGFB1 and systemic sclerosis.